Society for Vascular Medicine 2019 Annual Scientific Sessions Tetali et al May 2019
Pilot Study to Evaluate Effect of Antihypertensive Therapy on the Rates of Clinical Events in Patients with Vascular Ehlers-Danlos Syndrome
Journal of the American College of Cardiology 2019; 73:194857 Frank Peer Reviewed Publication
Audio summary by Editor-in-Chief of JACC, Dr. Valentin Fuster
Vascular Ehlers-Danlos Syndrome: Publication
Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study
Lancet 2010; 376: 1476-84 Ong Peer Reviewed Publication
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial
NORD Poster Presentation Grabowsky October 2018
Big Data Analytics to Estimate Prevalence of Ehlers-Danlos Syndrome
(Vascular Phenotype) and Rate of Rupture Events
Cardiology in Review 2017; 25: 247-253 Nawarskas Peer Reviewed Publication
Celiprolol, A Unique Selective Adrenoceptor Modulator
Genetics in Medicine 2014; 16(12): 881-8 Pepin Peer Reviewed Publication
Survival is affected by mutation type and molecular mechanism in vascular EhlersDanlos syndrome (EDS type IV)
Cardiovascular Research 2019; cvz095 Dubacher Peer Reviewed Publication
Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers Danlos syndrome